BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 24003922)

  • 1. Metagenome and metabolism: the tissue microbiota hypothesis.
    Burcelin R; Serino M; Chabo C; Garidou L; Pomié C; Courtney M; Amar J; Bouloumié A
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 3():61-70. PubMed ID: 24003922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intestinal microbiota and novel therapeutic perspectives for the treatment of metabolic diseases].
    Burcelin R; Chabo C; Blasco-Baque V; Sérino M; Amar J
    Med Sci (Paris); 2013; 29(8-9):800-6. PubMed ID: 24005637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of metabolism: a cross talk between gut microbiota and its human host.
    Burcelin R
    Physiology (Bethesda); 2012 Oct; 27(5):300-7. PubMed ID: 23026753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Programming of host metabolism by the gut microbiota.
    Bäckhed F
    Ann Nutr Metab; 2011; 58 Suppl 2():44-52. PubMed ID: 21846980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota as a regulator of energy homeostasis and ectopic fat deposition: mechanisms and implications for metabolic disorders.
    Musso G; Gambino R; Cassader M
    Curr Opin Lipidol; 2010 Feb; 21(1):76-83. PubMed ID: 19915460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury.
    Frazier TH; DiBaise JK; McClain CJ
    JPEN J Parenter Enteral Nutr; 2011 Sep; 35(5 Suppl):14S-20S. PubMed ID: 21807932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immuno-microbiota cross and talk: the new paradigm of metabolic diseases.
    Burcelin R; Garidou L; Pomié C
    Semin Immunol; 2012 Feb; 24(1):67-74. PubMed ID: 22265028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the gut microbiota on obesity and glucose homeostasis.
    Greiner T; Bäckhed F
    Trends Endocrinol Metab; 2011 Apr; 22(4):117-23. PubMed ID: 21353592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal MicrobiOMICS to define health and disease in human and mice.
    Serino M; Chabo C; Burcelin R
    Curr Pharm Biotechnol; 2012 Apr; 13(5):746-58. PubMed ID: 22122483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New insights into adipose cell biology].
    Burcelin R
    Bull Acad Natl Med; 2013 Jan; 197(1):79-92. PubMed ID: 24672981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbiota and diabetes: an evolving relationship.
    Tilg H; Moschen AR
    Gut; 2014 Sep; 63(9):1513-21. PubMed ID: 24833634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The intestinal microbiota and obesity.
    Kallus SJ; Brandt LJ
    J Clin Gastroenterol; 2012 Jan; 46(1):16-24. PubMed ID: 22064556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbes on-air: gut and tissue microbiota as targets in type 2 diabetes.
    Serino M; Blasco-Baque V; Burcelin R
    J Clin Gastroenterol; 2012 Oct; 46 Suppl():S27-8. PubMed ID: 22955352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of interactions between intestinal microbiota and intestinal macrophages on health.
    Nakata K; Yamamoto M; Inagawa H; Soma G
    Anticancer Res; 2013 Jul; 33(7):2849-53. PubMed ID: 23780969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host-gut microbiota metabolic interactions.
    Nicholson JK; Holmes E; Kinross J; Burcelin R; Gibson G; Jia W; Pettersson S
    Science; 2012 Jun; 336(6086):1262-7. PubMed ID: 22674330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host responses to the human microbiome.
    Bäckhed F
    Nutr Rev; 2012 Aug; 70 Suppl 1():S14-7. PubMed ID: 22861802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Microbiotes and metabolic diseases: the bases for therapeutic strategies].
    Burcelin R; Nicolas S; Blasco-Baque V
    Med Sci (Paris); 2016 Nov; 32(11):952-960. PubMed ID: 28008835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The gut microbiota, obesity and insulin resistance.
    Shen J; Obin MS; Zhao L
    Mol Aspects Med; 2013 Feb; 34(1):39-58. PubMed ID: 23159341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The gut microbiota elicits a profound metabolic reorientation in the mouse jejunal mucosa during conventionalisation.
    El Aidy S; Merrifield CA; Derrien M; van Baarlen P; Hooiveld G; Levenez F; Doré J; Dekker J; Holmes E; Claus SP; Reijngoud DJ; Kleerebezem M
    Gut; 2013 Sep; 62(9):1306-14. PubMed ID: 22722618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intestinal microbiota, obesity and insulin resistance].
    Pernet A; Petriccioli N
    Rev Med Suisse; 2011 Nov; 7(317):2236-8. PubMed ID: 22400352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.